They showed that VB stimulates the HIPK2–p53 signaling pathway, thus inhibiting cell proliferation and promoting apoptosis in colon cancer [62] (Table 1), pointing again to the key role of a functional HIPK2–p53 axis for achieving efficient tumor cell death in response to cytotoxic therapies [26]. Here, TP53 is linked to malignant colon neoplasm.